vs
Side-by-side financial comparison of AMBARELLA INC (AMBA) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
AMBARELLA INC is the larger business by last-quarter revenue ($108.5M vs $76.2M, roughly 1.4× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -13.9%, a 21.3% gap on every dollar of revenue. On growth, AMBARELLA INC posted the faster year-over-year revenue change (31.2% vs 25.5%). AMBARELLA INC produced more free cash flow last quarter ($31.4M vs $9.7M). Over the past eight quarters, AMBARELLA INC's revenue compounded faster (45.0% CAGR vs 22.7%).
Ambarella, Inc. is an American fabless semiconductor design company, focusing on low-power, high-definition (HD) and Ultra HD video compression, image processing, and computer vision processors. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver and in-cabin monitoring, autonomous driving, and robotics applications. Ambarella's system on chips ...
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
AMBA vs VMD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $108.5M | $76.2M |
| Net Profit | $-15.1M | $5.6M |
| Gross Margin | 59.6% | 57.9% |
| Operating Margin | -15.0% | 11.0% |
| Net Margin | -13.9% | 7.4% |
| Revenue YoY | 31.2% | 25.5% |
| Net Profit YoY | 37.2% | 30.7% |
| EPS (diluted) | $-0.35 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $108.5M | $76.2M | ||
| Q3 25 | $95.5M | $71.9M | ||
| Q2 25 | $85.9M | $63.1M | ||
| Q1 25 | $84.0M | $59.1M | ||
| Q4 24 | $82.7M | $60.7M | ||
| Q3 24 | $63.7M | $58.0M | ||
| Q2 24 | $54.5M | $55.0M | ||
| Q1 24 | $51.6M | $50.6M |
| Q4 25 | $-15.1M | $5.6M | ||
| Q3 25 | $-20.0M | $3.5M | ||
| Q2 25 | $-24.3M | $3.2M | ||
| Q1 25 | $-20.2M | $2.6M | ||
| Q4 24 | $-24.1M | $4.3M | ||
| Q3 24 | $-34.9M | $3.9M | ||
| Q2 24 | $-37.9M | $1.5M | ||
| Q1 24 | $-60.6M | $1.6M |
| Q4 25 | 59.6% | 57.9% | ||
| Q3 25 | 58.9% | 57.5% | ||
| Q2 25 | 60.0% | 58.3% | ||
| Q1 25 | 60.0% | 56.3% | ||
| Q4 24 | 60.6% | 59.5% | ||
| Q3 24 | 60.8% | 59.3% | ||
| Q2 24 | 60.9% | 59.8% | ||
| Q1 24 | 59.8% | 58.9% |
| Q4 25 | -15.0% | 11.0% | ||
| Q3 25 | -23.0% | 7.8% | ||
| Q2 25 | -30.1% | 8.1% | ||
| Q1 25 | -30.2% | 6.5% | ||
| Q4 24 | -30.9% | 10.6% | ||
| Q3 24 | -56.9% | 9.7% | ||
| Q2 24 | -72.4% | 6.6% | ||
| Q1 24 | -80.8% | 4.4% |
| Q4 25 | -13.9% | 7.4% | ||
| Q3 25 | -20.9% | 4.9% | ||
| Q2 25 | -28.3% | 5.0% | ||
| Q1 25 | -24.1% | 4.4% | ||
| Q4 24 | -29.1% | 7.1% | ||
| Q3 24 | -54.8% | 6.7% | ||
| Q2 24 | -69.6% | 2.7% | ||
| Q1 24 | -117.4% | 3.2% |
| Q4 25 | $-0.35 | $0.14 | ||
| Q3 25 | $-0.47 | $0.09 | ||
| Q2 25 | $-0.58 | $0.08 | ||
| Q1 25 | $-0.48 | $0.06 | ||
| Q4 24 | $-0.58 | $0.10 | ||
| Q3 24 | $-0.85 | $0.10 | ||
| Q2 24 | $-0.93 | $0.04 | ||
| Q1 24 | $-1.51 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.1M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $590.1M | $141.5M |
| Total Assets | $751.9M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $174.1M | $13.5M | ||
| Q3 25 | $142.7M | $11.1M | ||
| Q2 25 | $141.3M | $20.0M | ||
| Q1 25 | $144.6M | $10.2M | ||
| Q4 24 | $127.1M | $17.5M | ||
| Q3 24 | $153.9M | $11.3M | ||
| Q2 24 | $131.8M | $8.8M | ||
| Q1 24 | $144.9M | $7.3M |
| Q4 25 | $590.1M | $141.5M | ||
| Q3 25 | $576.5M | $133.6M | ||
| Q2 25 | $572.7M | $139.7M | ||
| Q1 25 | $561.4M | $134.8M | ||
| Q4 24 | $554.3M | $131.4M | ||
| Q3 24 | $547.6M | $125.0M | ||
| Q2 24 | $555.4M | $119.4M | ||
| Q1 24 | $559.9M | $116.3M |
| Q4 25 | $751.9M | $199.2M | ||
| Q3 25 | $706.4M | $202.4M | ||
| Q2 25 | $701.9M | $184.6M | ||
| Q1 25 | $689.0M | $178.1M | ||
| Q4 24 | $670.8M | $177.1M | ||
| Q3 24 | $650.3M | $169.5M | ||
| Q2 24 | $638.7M | $163.9M | ||
| Q1 24 | $657.7M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.3M | $18.4M |
| Free Cash FlowOCF − Capex | $31.4M | $9.7M |
| FCF MarginFCF / Revenue | 29.0% | 12.7% |
| Capex IntensityCapex / Revenue | 2.7% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $64.3M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.3M | $18.4M | ||
| Q3 25 | $5.5M | $18.4M | ||
| Q2 25 | $14.8M | $12.3M | ||
| Q1 25 | $25.4M | $2.9M | ||
| Q4 24 | $6.6M | $15.0M | ||
| Q3 24 | $16.7M | $12.7M | ||
| Q2 24 | $-15.0M | $10.2M | ||
| Q1 24 | $-4.0M | $1.2M |
| Q4 25 | $31.4M | $9.7M | ||
| Q3 25 | $1.4M | $10.7M | ||
| Q2 25 | $10.2M | $4.1M | ||
| Q1 25 | $21.2M | $-12.6M | ||
| Q4 24 | $4.1M | $3.2M | ||
| Q3 24 | $14.2M | $1.7M | ||
| Q2 24 | $-16.1M | $1.2M | ||
| Q1 24 | $-6.0M | $-4.8M |
| Q4 25 | 29.0% | 12.7% | ||
| Q3 25 | 1.4% | 14.9% | ||
| Q2 25 | 11.9% | 6.5% | ||
| Q1 25 | 25.3% | -21.4% | ||
| Q4 24 | 5.0% | 5.2% | ||
| Q3 24 | 22.2% | 3.0% | ||
| Q2 24 | -29.5% | 2.3% | ||
| Q1 24 | -11.6% | -9.5% |
| Q4 25 | 2.7% | 11.5% | ||
| Q3 25 | 4.3% | 10.6% | ||
| Q2 25 | 5.3% | 12.9% | ||
| Q1 25 | 5.0% | 26.2% | ||
| Q4 24 | 3.0% | 19.5% | ||
| Q3 24 | 4.0% | 19.0% | ||
| Q2 24 | 2.1% | 16.3% | ||
| Q1 24 | 3.7% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMBA
| TW | $76.0M | 70% |
| Asia Pacific Other Than Taiwan | $20.2M | 19% |
| North America Other Than United States | $7.4M | 7% |
| Other | $5.0M | 5% |
VMD
Segment breakdown not available.
